Concepedia

Andrew Mike Rauth

AM

Statistics

Publications

4

Citations

502

H-Index

4

Active since

2004

Affiliations

University of Toronto(Current)

Ontario Institute for Cancer Research

Andrew Mike Rauth is an author at University of Toronto specializing in cancer nanomedicine, drug delivery, and nanomedicine.

Publications per year

2004–2023

4

Publications

4

Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer

Ho Lun Wong, Reina Bendayan, Andrew Mike Rauth et al. · Journal of Controlled Release · 2006 · 205 citations

, , +17

Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers

Ho Lun Wong, Reina Bendayan, Andrew Mike Rauth et al. · Journal of Pharmaceutical Sciences · 2004 · 176 citations

, , +14

In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model

Ho Lun Wong, Andrew Mike Rauth, Reina Bendayan et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2006 · 107 citations

, , +16

Development and psychometric testing of a competency of nursing process questionnaire

Virya Koy, Jintana Yunibhand, Andrew Mike Rauth et al. · International Journal of Nursing Sciences · 2023 · 14 citations · Full text

, , +16

1–4 of 4